¡¡
Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorrow. They turn to Pharma Koreana for its unique monthly package of Korean pharmaceutical news, analyses, commentaries and data. ¡¡
          
¡¡
There are 21 News items on Display.
Latest News¡¡

HighLight

1. Huons to develop a new natural drug for the treatment of fatty liver

Huons, a KOSDAQ-listed pharmaceutical firm focusing on the development of new natural drugs, announced that its development of drug for the ..

 

December 27th, 2011

2. Dong-A licenses out Zydena to Meiji Seika of Japan

Dong-A Pharm recently signed an agreement with Meiji Seika Pharm (Japan) to license out Zydena (udenafil) tab. for a new indication to treat ..

 

December 27th, 2011

3. GMP guidelines related to the use of an excessive amount of active ingredients prepared

The KFDA prepared GMP guidelines related to the use of an excessive amount of certain active ingredients in the process of manufacture of fi ..

 

December 27th, 2011

more ...
Business News

4. Approval of new drugs heats the stock market

Four pharmaceutical firms¡¯ stock prices increased by 8.4 percent to 61.3 percent as of January 9th, 2012 from the lowest of the points recor ..

 

January 25th, 2012

5. Viromed obtains a Russian patent for its gene therapy

Viromed, a local bio-venture company, recently obtained a Russian patent titled ¡®treatment and prevention of cardiac conditions using two or ..

 

January 25th, 2012

6. Hana to export a narcotic analgesic worth $1 million to Thailand

Hana Pharm recently signed an agreement to export Fentas (fentanyl) patch worth about $1 million to Thailand. Fentas, a narcotic analgesic p ..

 

January 25th, 2012

7. Top ten local pharmaceutical firms estimated to record an average sales growth of just 1.2% in 2011

Analysis of data from securities companies showed that the top ten local pharmaceutical firms were estimated to record an average sales gr ..

 

January 25th, 2012

8. Twynsta in the antihypertensive market and Albis in the anti-ulcer drug market achieved rapid growth in December 2011

According to the UBIST data, Twynsta achieved sales of 3.8 billion won and a sales growth of as much as 264.1 percent in December 2011, ..

 

January 25th, 2012

more ...
Policy and Regulatory

9. Savings in drug expenditures from the use of relatively-low priced substitute drugs not large as expected

The Korea Institute for Health and Social Affairs (KIHASA) analyzed statistical data for consumption and sales of drugs for year 2010. The K ..

 

January 25th, 2012

10. Bonus points to be added to prices of innovative new drugs over three years

The Ministry for Health, Welfare and Family Affairs (MIHWAF) decided to grant bonus points to ¡®innovative new drugs showing therapeutic usef ..

 

January 25th, 2012

more ...
Bio industry news

11. Korea Green Cross¡¯ Hunterase for the treatment of Hunter syndrome approved by the KFDA

Korea Green Cross announced that the KFDA recently approved Hunterase (idursulfase-beta) inj., the world¡¯s second drug for the treatment of ..

 

January 25th, 2012

12. IND application for Schnell Biopharm¡¯s biosimilar version of Remicade approved in Japan

Schnell Biopharm, a KOSPI-listed pharmaceutical firm, recently announced that its partner, Nichi-Iko Pharm of Japan, obtained approval for ..

 

January 25th, 2012

13. Sewon Cellontech¡¯s two biocollagen-based filler products for the regeneration of bones approved by the KFDA

Sewon Cellontech announced that the KFDA approved OssFill and SurgiFill, medical devices. Sewon Cellontech previously obtained European conf ..

 

January 25th, 2012

more ...
R & D

14. Wooridul to develop new natural drugs

Wooridul Pharm, a local pharmaceutical firm, recently signed an MOU with Lapians, a local beauty and health care company, to jointly develop ..

 

January 25th, 2012

15. Huons developing four new natural drugs

Huons, a KOSDAQ-listed pharmaceutical firm focusing on the development of new natural drugs, has spent about 5 percent of its sales as R&a ..

 

January 25th, 2012

16. Bukwang files IND application for a clevudine/adefovir combination drug for the treatment of hepatitis B

Bukwang Pharm recently filed its Investigational New Drug (IND) application for a phase I clinical trial for a clevudine/adefovir combinatio ..

 

January 17th, 2012

more ...
Patent

17. Generic companies lose patent nullification suits against Renexin

The Korean Intellectual Property Tribunal ruled that SK Chemicals¡¯ patent for Renexin (cilostazol + Ginkgo leaf extract) tab., a combination ..

 

January 25th, 2012

18. Sewon Cellontech obtains two Japanese patents related to cell culture facilities

Sewon Cellontech recently obtained two Japanese patents titled ¡®cell manipulation and cultivation equipments for the production of cell th ..

 

January 25th, 2012

19. Bioneer obtains a Korean patent for human milk-derived lactic acid bacteria

Bioneer, a local biotechnology company, recently obtained a Korean patent titled ¡®human milk-derived lactic acid bacteria having probiotic ..

 

January 25th, 2012

more ...
Company profile

20. Summary of Korea Pharmaceutical Manufacturer

Summary of Korean Pharmaceutical Manufacturer (Jeil Pharm & Cheil Jedang Corp. )Please download the attached file.

 

December 30th, 2011

21. Summary of Korea Pharmaceutical Manufacturer

Summary of Korea Pharmaceutical Manufacturer (Hanlim Pharm)Please download the attached file.

 

November 30th, 2011

more ...
¡¡
Pharma Koreana Ltd. 9F, KAMCO Yangjae Tower, 949-3, Dogok-dong Gangnam-gu, Seoul 135-270, Korea Tel:(82)2-554-9591 Fax:(82)2-563-8289 ¡¡ ¡¡

Email:Pkinfo@Pharmakoreana.com
Subscriptions:Pkinfo@Pharmakoreana.com

¡¡

¡¡